An improved method on stimulated T-lymphocytes to functionally characterize novel and known LDLR mutations

Area of Science:

• Genetics and Molecular Biology
• Clinical Diagnostics
• Biochemistry

Background:

• Familial hypercholesterolemia (FH) is primarily caused by mutations in the LDL receptor (LDLR) gene.
• Functional studies are crucial for understanding LDLR impairment and for diagnosing FH.
• Differentiating between FH patients and healthy individuals requires precise methods for assessing LDLR activity.

Purpose of the Study:

• To identify the most effective method for detecting LDL receptor (LDLR) activity.
• To compare the diagnostic utility of stimulated T-lymphocytes versus Epstein-Barr virus (EBV)-transformed B-lymphocytes for LDLR function assessment.
• To characterize novel and known mutations within the LDLR gene.

Main Methods:

• Collected peripheral blood from 24 FH patients and 24 control subjects.
• Isolated and utilized both mitogen-stimulated T-lymphocytes and continuous EBV-transformed B-lymphocytes.
• Performed functional assays using fluorescent LDL and flow cytometry to measure residual LDLR activity, normalizing fluorescence data against control means.

Main Results:

• Stimulated T-lymphocytes demonstrated superior discrimination between FH patients and controls compared to EBV-transformed B-lymphocytes, evidenced by receiver operating characteristic (ROC) curve analysis (Area Under Curve: 1.000 vs. 0.984, P < 0.0001).
• The T-lymphocyte method proved simpler and faster for evaluating LDLR activity.
• Complete discrimination between control and FH patient groups was achieved using the T-lymphocyte assay.

Conclusions:

• Evaluating residual LDLR activity using stimulated T-lymphocytes is a highly effective diagnostic tool for familial hypercholesterolemia.
• This method offers significant advantages in simplicity, speed, and diagnostic accuracy over EBV-transformed B-lymphocytes.
• The T-lymphocyte approach aids in both mutation characterization and clinical diagnosis of FH.